/RBOT
RBOT Stock - Vicarious Surgical Inc.
Healthcare|Medical - DevicesNYSE
$2.17-1.81%
$0.04 (-1.81%) • Dec 19
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.59
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+245.6%upside
Target: $7.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RBOT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.15 – $2.19
TARGET (TP)$7.50
STOP LOSS$2.00
RISK/REWARD1:31.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.52
52W High$18.97
52W Low$2.16
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-2,107,000 | $-1,854,000 | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-66,555,000 | $-80,666,000 | $-80,078,000 | $-38,223,000 | $-12,985,000 |
| Net Income | $-63,223,000 | $-71,071,000 | $5.16M | $-35,207,000 | $-12,875,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-10.72 | $-14.70 | $1.27 | $-10.92 | $-3.76 |
Company Overview
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RBOTBeat Rate
53%
Last 17 quarters
Avg Surprise
-11.9%
EPS vs Estimate
Beats / Misses
9/8
Last 12 quarters
Latest EPS
$-1.91
Q4 2025
EPS Surprise History
Q1 24
+41.7%
$-2.10vs$-3.60
Q2 24
+10.0%
$-2.70vs$-3.00
Q3 24
+4.0%
$-2.86vs$-2.98
Q4 24
-10.0%
$-2.87vs$-2.61
Q1 25
+9.7%
$-2.43vs$-2.69
Q2 25
+1.1%
$-2.58vs$-2.61
Q3 25
+14.6%
$-2.23vs$-2.61
Q4 25
+19.4%
$-1.91vs$-2.37
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Mar 16, 2026 | $-1.37 | — | — | — |
Q4 2025 | Nov 12, 2025 | $-2.37 | $-1.91 | +19.4% | ✓ BEAT |
Q3 2025 | Aug 12, 2025 | $-2.61 | $-2.23 | +14.6% | ✓ BEAT |
Q2 2025 | May 12, 2025 | $-2.61 | $-2.58 | +1.1% | ✓ BEAT |
Q1 2025 | Mar 17, 2025 | $-2.69 | $-2.43 | +9.7% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $-2.61 | $-2.87 | -10.0% | ✗ MISS |
Q3 2024 | Aug 12, 2024 | $-2.98 | $-2.86 | +4.0% | ✓ BEAT |
Q2 2024 | Apr 29, 2024 | $-3.00 | $-2.70 | +10.0% | ✓ BEAT |
Q1 2024 | Mar 4, 2024 | $-3.60 | $-2.10 | +41.7% | ✓ BEAT |
Q4 2023 | Nov 13, 2023 | $-4.50 | $-3.60 | +20.0% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | $-3.90 | $-4.80 | -23.1% | ✗ MISS |
Q2 2023 | May 8, 2023 | $-2.70 | $-5.11 | -89.3% | ✗ MISS |
Q1 2023 | Feb 13, 2023 | $-5.41 | $-4.80 | +11.3% | ✓ BEAT |
Q4 2022 | Nov 7, 2022 | $-4.50 | $-5.41 | -20.2% | ✗ MISS |
Q3 2022 | Aug 8, 2022 | $-4.20 | $-4.80 | -14.3% | ✗ MISS |
Q2 2022 | May 9, 2022 | $-3.90 | $-4.50 | -15.4% | ✗ MISS |
Q1 2022 | Mar 3, 2022 | $-3.30 | $-4.50 | -36.4% | ✗ MISS |
Q4 2021 | Nov 8, 2021 | $-1.20 | $-2.70 | -125.0% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | — | $-2.27 | — | — |
Latest News
Vicarious Surgical Sees FY26 Full-Year Cash Burn ~$35M
➖ NeutralBenzinga•Dec 15, 2025, 01:40 PM
Vicarious Surgical Files Prospectus To Offer Up To $100M In Stock, Debt, Warrants And Units On NYSE
➖ NeutralBenzinga•Dec 12, 2025, 09:39 PM
Shares of robotics-linked stocks are trading lower. Last week, the stock rallied after a Politico report suggested that the Trump administration is considering issuing an executive order on robotics next year.
📉 NegativeBenzinga•Dec 8, 2025, 05:56 PM•Also: , ,
Vicarious Surgical Has Been Granted Canadian Patent Number 3167157 Titled "SYSTEM AND METHOD FOR DETERMINING DEPTH PERCEPTION IN VIVO IN A SURGICAL ROBOTIC SYSTEM"
📈 PositiveBenzinga•Dec 3, 2025, 08:59 PM
Vicarious Surgical stock up after improved cash burn guidance
📈 PositiveSeeking Alpha•Dec 3, 2025, 12:44 PM
Vicarious Surgical Lowers Full Year 2025 Cash Burn Outlook To $45.0M Improving Prior $50.0M Guidance By $5.0M
📈 PositiveBenzinga•Dec 3, 2025, 12:23 PM
Vicarious Surgical Q3 Adj. EPS $(1.91) Beats $(2.33) Estimate
📈 PositiveBenzinga•Nov 12, 2025, 09:17 PM
Vicarious Surgical raises $5.9M in direct and private placement offering; shares down
📉 NegativeSeeking Alpha•Oct 8, 2025, 11:14 AM
Vicarious Surgical Prices $5.9M Share Offering At $5.10/Share And Accompanying Warrants, And Pre-Funded Warrant And Accompanying Warrants At $5.0999
➖ NeutralBenzinga•Oct 8, 2025, 11:07 AM
Vicarious Surgical Appoints Joseph Doherty As Board Chairman
➖ NeutralBenzinga•Sep 25, 2025, 08:18 PM
Vicarious Surgical Narrows Loss in Q2
📈 PositiveThe Motley Fool•Aug 13, 2025, 02:29 AM
Frequently Asked Questions about RBOT
What is RBOT's current stock price?
Vicarious Surgical Inc. (RBOT) is currently trading at $2.17 per share. The stock has moved -1.81% today.
What is the analyst price target for RBOT?
The average analyst price target for RBOT is $7.50, based on 1 analyst.
What sector is Vicarious Surgical Inc. in?
Vicarious Surgical Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NYSE exchange.
What is RBOT's market cap?
Vicarious Surgical Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does RBOT pay dividends?
No, Vicarious Surgical Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBOLD
Boundless Bio, Inc.
$1.22
Mkt Cap: $0.0B
HYPD
Hyperion DeFi, Inc.
$3.67
Mkt Cap: $0.0B
INTS
Intensity Therapeutics, Inc.
$0.41
Mkt Cap: $0.0B
ITRM
Iterum Therapeutics plc
$0.37
Mkt Cap: $0.0B
MODD
Modular Medical, Inc.
$0.34
Mkt Cap: $0.0B
MYO
Myomo, Inc.
$0.93
Mkt Cap: $0.0B
NXL
Nexalin Technology, Inc.
$0.83
Mkt Cap: $0.0B
PIII
P3 Health Partners Inc.
$4.12
Mkt Cap: $0.0B
PSTV
Plus Therapeutics, Inc.
$0.57
Mkt Cap: $0.0B
QTTB
Q32 Bio Inc.
$2.96
Mkt Cap: $0.0B
Explore stocks similar to RBOT for comparison